Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7856)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2023 (publication date) through Feb 23, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol 2023; 29(37): 5292-5304 [PMID: 37899787 DOI: 10.3748/wjg.v29.i37.5292] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol 2023; 29(37): 5292-5304 [PMID: 37899787 DOI: 10.3748/wjg.v29.i37.5292] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v29/i37/5292.htm |
| Number | Citing Articles |
| 1 |
Vasiliy Ivanovich Reshetnyak, Elena Vladimirovna Vinnitskaya, Igor Veniaminovich Maev. Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. World Journal of Gastrointestinal Pathophysiology 2025; 16(2): 107347 doi: 10.4291/wjgp.v16.i2.107347
|
| 2 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(1077) |
Core Tip(1041) |
Full Article(HTML)(4624)
|
Full Article with Cover (PDF)-1825K(374)
|
Full Article (Word)-130K(43)
|
Audio-14227K(32)
|
Peer-Review Report-222K(191)
|
Answering Reviewers-194K(143)
|
Full Article (PDF)-407K(284)
|
Full Article (XML)-119K(176)
|
Times Cited (0)
|
Total Visits (14416)
|
Open
|
| 3 |
Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guocai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng. Advances, challenges and future applications of liver organoids in experimental regenerative medicine. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1521851
|
| 4 |
Klairi Papachristou, Maria Angelara, Konstantinos Manganas, Theodoros Androutsakos. Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review. International Journal of Molecular Sciences 2026; 27(3): 1388 doi: 10.3390/ijms27031388
|
| 5 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitis. Exploration of Immunology 2024; : 624 doi: 10.37349/ei.2024.00163
|
| 6 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. An Integrated Pathogenetic Model of Primary Biliary Cholangitis. Livers 2025; 5(2): 15 doi: 10.3390/livers5020015
|
| 7 |
Hengli Luo, Long Han, Kai He, Kun Chen, Qiming Wei, Chengbin Zhang, Longyang Jiang. Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization study. Medicine 2025; 104(40): e44873 doi: 10.1097/MD.0000000000044873
|
| 8 |
Vasiliy I Reshetnyak, Igor V Maev. Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. World Journal of Experimental Medicine 2025; 15(1): 101771 doi: 10.5493/wjem.v15.i1.101771
|
| 9 |
Hong-Li Liu, Xing Liu, Yi-Fan Hu, Xi-Xuan Wang, Yu Zhang, Li Wang, Sha-Sha Li, Yi-Jun Bao, Si-Wei Zheng, Qing-Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Huang, Xiao-Ning Feng, Wen-Quan Zeng, Cai-Yun Zhang, Kai Zhang, Yong-Feng Yang. Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04280-5
|
| 10 |
Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine 2025; 14(23): 8503 doi: 10.3390/jcm14238503
|
| 11 |
Kun Yang, Bingqing Yang, Jiamin Chen, Lili Gao, Xiaoyi Han, Junke Hu, Liang Zhang, Xiangmei Chen, Qi Wang, Xingang Zhou, Ting Liu, Xuefei Duan, Lei Sun. Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid. BMC Gastroenterology 2026; doi: 10.1186/s12876-026-04686-9
|
| 12 |
Armando Curto, Rocco G Iamello, Erica N Lynch, Andrea Galli. Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies. World Journal of Clinical Cases 2025; 13(30): 109028 doi: 10.12998/wjcc.v13.i30.109028
|
| 13 |
Filippo Gabrielli, Eleonora Crepaldi, Alessia Cavicchioli, Marco Rivi, Arianna Carmen Costanzo, Carmela Cursaro, Pietro Andreone. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments. Biomolecules 2024; 14(10): 1227 doi: 10.3390/biom14101227
|
| 14 |
Magdalena Rogalska, Paweł Rogalski, Aleksandra Andrzejuk, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Robert Flisiak. Lipidome remodeling in primary biliary cholangitis. Lipids in Health and Disease 2026; doi: 10.1186/s12944-026-02887-5
|